The US Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment administered to US President Donald Trump, which said which helped cure him of the disease. “Licensing these monoclonal antibody therapies can help outpatients avoid hospitalization and ease …
Read More »